Programme
One-on-one meetings
From 9:00 - 19:00, we have reserved several meeting rooms for one-on-one meetings. Therefore, every delegate will get optimal opportunities for building up and strengthening ties among international and national life science players. As part of the event, we offer our international guests to assist in identifying relevant local biotech companies. Booking schemes will be available all day at the registration desk.
Programme plenum sessions
|
08:00
|
Breakfast & registration
|
|
09:00
|
Welcome session
- hosted by Medicon Valley Alliance and PricewaterhouseCoopers
-
Barbara Dalton, Vice President, Venture Capital, Pfizer (US)
-
Jo Pisani, Director, Market & Value Advisory, PricewaterhouseCoopers (UK)
-
Ben Wilcox, Director, Licensing Management Services, PricewaterhouseCoopers (UK)
|
|
10:45
|
Break
|
|
11:15
|
Outsourcing of non-clinical and clinical activities
-
Andy Makin, CEO, LAB Scantox (CAN/DK)
-
Yvonne Lech, CEO, Capio Diagnostik (DK)
-
Claes Strøm, Director of Clinical Operations, aCROnordic (DK)
|
|
12:30
|
Lunch
|
|
13:30
|
Approaching big pharma
-
Håkan Garpenstrand, Head of Licensing Scandinavia, Wyeth (S)
-
Hans Boström, Director, Scientific Liason, Scandinavia & Baltic Countries, Merck Sharpe & Dohme (S)
-
Jørn Roland Müller, Vice President, Biopharmaceuticals Sourcing, Novo Nordisk (DK)
-
Ole Vahlgren, Vice President, Head of Corporate Business Development & Strategy, H. Lundbeck (DK)
|
|
15:00
|
Break
|
|
15:30
|
Great license agreements
-
Genmab/GSK: Sherrie Preische, Director Business Development, Genmab (US)
-
BioInvent/Genentech: Cristina Glad, Executive Vice President, BioInvent (S)
|
|
17:00
|
Closing remarks
|